Analyst updates Amedica shares to ‘buy’ rating — 4 notes

Ladenburg Thalmann gave Amedica a “buy” rating on Jan. 5, according to Risers & Fallers.

Advertisement

Here are four notes:

 

1. Ladenburg Thalmann has a $0.35 price target on Amedica’s stock.

 

2. Amedica reports a market cap of $20.56 million.

 

3. During the last trading session, Amedica’s share price dropped 4.02 percent.

 

4. During the trading session, 417,005 Amedica shares were traded.

 

More articles on devices:
6 things to know about Johnson & Johnson’s stock: Is there long-term strength?
Pacira’s 2015 revenue hits $249M: 5 things to know
Fidia Farmaceutici to introduce treatment for OA-related knee pain — 5 things to know

 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.